Skip to main content
. 2023 May 30;18(5):e0286364. doi: 10.1371/journal.pone.0286364

Table 5. Cardiovascular outcomes between AT and NAT groups.

Outcomes AT N (%) NAT N (%) Total N (%) P Value
MACE (HF/CAD/MI/arrhythmia, death)
HF: Systolic 17 (27.4) 6 (10.9) 23 (19.7) 0.025*
HF: Diastolic 14 (22.6) 16 (29) 30 (25.6) 0.421
CAD/MI 7 (11.3) 9 (16.3) 15 (12.8) 0.425
Arrhythmia 21 (33.8) 23 (41.8) 44(37.6) 0.376
Valvular disease 6 (9.7) 7 (13.4) 13 (11.1) 0.527
Death 3 (4.8) 4 (7.7) 7 (6.0) 0.579